No Detail Found!

Cardioprotective effect of boswellic acids against doxorubicin induced myocardial infarction in rats

Author(s)
Muhammad Hassaan Shahid Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Irfan Anjum Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Muhammad Naveed Mushtaq Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Saba Riaz National Hospital and Medical Centre,132/2 Street 123, Sector L, DHA, Phase-I, Lahore,Pakistan
Abstract
The aim of the present study was to evaluate the cardioprotective activity of boswellic acids in doxorubicin (DOX) induced cardiotoxicity. DOX (2.5mg/kg) was used intraperitoneally in rats to induce cardiotoxicity in six divided doses every alternate day over a period of two weeks. Dexrazoxane (10:1) was used as a standard drug. Boswellic acids (250, 500 and 750 mg/kg) were orally administered to rats for 14 days. After 14 days, rats were sacrificed, and blood was withdrawn through cardiac puncture. The blood lipid profile and cardiac biomarkers including LDH, CK-MB, CPK, SGOT and troponin T were measured. The heart of rats was isolated for histopathological studies. Graphpad Prism was used for statistical analysis. There was a significant increase in the level of cardiac enzymes and complete lipid profile parameters in diseased group as compared to control group. Pre-treatment with boswellic acids decreased level of all the measured parameters and decreased the severity of myocardial damage as supported by histopathological studies. It was concluded that boswellic acids possess cardioprotective potential by lowering cardiac biomarkers and blood lipid profile. Thus, boswellic acids might act as cardioprotective agent against doxorubicin induced cardiotoxicity.
Publication Details
Page(s) 359-365
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
Doxorubicin, cardioprotective, Cardiac Biomarkers, Boswellic acids
References
Ali SA,Zaitone SA,Moustafa YM .2015 .Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma. Cana J. Physio. Pharmacol., 93(8) : 695-708.
Behrouzian M,Najibi B,Haghi S,Mahdavi C,Ghaedi E .2020 .Prevalence of major cardiac events of anthracycline-induced cardiotoxicity in southwestern iran: different response patterns to cumulative dose. Cur. Drug Ther, 15(4) : 78-84.
Beniwal L,Khanna D,Dudi R,Mehan S R .2018 .Histoarchitectural and biochemical investigation of cardiac myocytes in rat model of isoproterenol-induced myocardial infarction with the exploration of boswellic acid. Pharmaspire, 10(2) : 87-94.
Geetha V,Chakravarthula SN .2018 .Chemical composition and anti-inflammatory activity of Boswellia ovalifoliolata essential oils from leaf and bark. J. Fores. Res., 29(2) : 373-381.
Griffin BR,Gist KM,Faubel S KM .2020 .Current status of novel biomarkers for the diagnosis of acute kidney injury: A historical perspective. J. Inten. Care Med, 35(5) : 415-424.
Hasinoff BB,Patel D,Wu X .2020 .The role of topoisomerase IIβ in the mechanisms of action of the doxorubicin cardioprotective agent dexrazoxane. Cardiovas. Toxicol., 20(3) : 312-320.
Henriksen PA .2018 .Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, 104(2) : 971-977.
Iram F,Khan SA,Husain A .2017 .Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review. Asian Pac. J. Trop. Biomed., 7(6) : 513-523.
Kelleni MT,Abdelbasset M .2018 .Drug Induced Cardiotoxicity: Mechanism, Prevention and Management. , : .
Khan MR,Khan M,Shah A .2018 .A study of heart enzyme profile in myocardial infarction. Scient. Inq. Rev., 2(2) : 01-10.
Koren O,Rozner E,Abu-Daoud I,Turgeman Y .2019 .Dynamic changes of troponin and creatine phosphokinase in acute myocarditis and non-st elevation myocardial infarction. J. Cardiovasc. Dis. Diagn., 7(6) : 2.
Liesse K,Harris J,Chan M,Schmidt ML,Chiu B .2018 .Dexrazoxane significantly reduces anthracycline-induced cardiotoxicity in pediatric solid tumor patients-a systematic review. J. Ped, 40(6) : 417.
Meier T,Gräfe K,Senn F,Sur P,Stangl GI,Dawczynski C,März W,Kleber ME,Lorkowski S ME .2019 .Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: A systematic analysis of the Global Burden of Disease Study. Eur. J. Epidemiol., 34(1) : 37-55.
Milwidsky A,Fisher E,Brzezinski RY,Ehrenwald M,Shefer G,Stern N,Shapira I,Zeltser D,Rosenbaum Z,Greidinger D Z .2019 .Metabolic syndrome is associated to high-sensitivity cardiac troponin T elevation. Biomarkers, 24(2) : 153-158.
Mubarak S,Hamid SA,Farrag AR,Samir N,Hussein JS .2018 .Atherogenic coefficient and atherogenic index in doxorubicin-induced cardiotoxicity: Impact of date palm extract. Comp. Clin. Path, 27 : 1515-1522.
Myburgh CE,Malan L,Wentzel A,Scheepers JDW,Malan NT .2019 .Coping and cardiac troponin T-A risk for hypertension and sub-clinical ecg left ventricular hypertrophy: The SABPA Study. , 28(6) : 908-916.
Nass RD,Motloch LJ,Paar V,Lichtenauer M,Baumann J,Zur B,Hoppe UC,Holdenrieder S,Elger CE,Surges R .2019 .Blood markers of cardiac stress after generalized convulsive seizures. Epilepsia, 60(2) : 201-210.
Niringiyumukiza JD,Cai H,Chen L,Li Y,Wang L,Zhang M,Xu X,Xiang W .2019 .Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve. , 116 : 108963.
Odum EP,Wakwe VC .2017 .Clinical significance of creatine Kinase-MB elevation in patients with chronic kidney disease before initiation of hemodialysis. , 6(4) : 1-7.
Oikonomou E,Anastasiou Q,Siasos G,Androulakis E,Psyrri A,Toutouzas K,Tousoulis D K .2018 .Cancer therapeutics-related cardiovascular complications. mechanisms, diagnosis and treatment. , 24(37) : 4424-4435.
Padulo J,Nikolaidis PT,Cular D,Dello Iacono A,Vando S,Galasso M,Lo Storto D and Ardigò L P .2018 .The effect of heart rate on jump-shot accuracy of adolescent basketball players. Front, : 1065.
Pudil R,Mueller C,Celutkiene J,Henriksen PA,Lenihan D,Dent S,Barac A,Stanway S,Moslehi J,Suter TM .2020 .Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: A position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the CardioOncology Council of the European Society of Cardiology. Eur. J. Heart Fail, 22(11) : 1966-1983.
SHAH S .2019 .Ayurveda: The Conventional Indian Medicine System and its Global practice. Himal. J. Health Sci., 4(1) : 13-33.
Shaker RA,Abboud SH,Assad HC,Hadi N HC .2018 .Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. BMC Pharmacol, 19(3) : 1-10.
Skubitz KM,Blaes AH,Konety SH,Francis GS .2017 .Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value. Cancer Chemo, 80(4) : 787-798.
Songbo M,Lang H,Xinyong C,Bin X,Ping Z,Liang S Z .2019 .Oxidative stress injury in doxorubicininduced cardiotoxicity. Toxicol. Letters, 307 : 41-48.
Bartels MN Syrkin G. .2018 .The role of rehabilitation medicine in managing cardiopulmonary complications of cancer. Cur. Phys. Med, : 121-130.
Szmit S,Jurczak W,Zaucha JM,Długosz-Danecka M,Sosnowska-Pasiarska B,Chmielowska E,Joks M,Drozd-Sokołowska J,Knopińska-Posłuszny W,Spychałowicz W .2017 .Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders. Int. J. Cardiol., 235 : 147-153.
Virshette S,Patil M,Shaikh JR .2020 .A review on pharmacological properties and phytoconstituents of indigenous carminative agents. J. Pharmacog. Phytochem., 9(3) : 142-145.
Vuddanda PR,Singh S,Velaga S S .2016 .Boswellic acid-Medicinal use of an ancient herbal remedy. J. Herb. Med, 6(4) : 163-170.
Yu Y,Jin L,Zhuang Y,Hu Y,Cang J,Guo K J .2018 .Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats. Int. J. Mol. Med, 41(6) : 3509-3516.
0

Citations

0

Downloads

7

Views